Evidence map›Paper›PMID 40485247›Full record

SynthesisTechnology in cancer research & treatment

Bolus Use in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic Literature Review.

Fengyan Li, Wendie Hu, Hanzong Li, Bohan Li, Yaxue Wang

Abstract readSystematic Review
In one paragraph

Synthesis in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fengyan LiDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou P. R. of China.ORCID 0009-0001-1319-8912
Wendie HuDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou P. R. of China.ORCID 0009-0004-9358-681X
Hanzong LiBiomedical Forensic Science, Boston University Chobanian & Avedisian School of Medicine: Graduate Medical Sciences, Boston, MA, USA.ORCID 0009-0005-4276-9808
Bohan LiDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou P. R. of China.ORCID 0009-0007-4263-0800
Yaxue WangDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou P. R. of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionTissue-equivalent boluses are used to increase the skin surface dose in patients with breast cancer undergoing postmastectomy radiotherapy. Boluses made from various materials have been developed and applied in clinical practice. However, there is currently no international standardization for their use. This study aimed to analyze the advantages and disadvantages of using compensatory membranes (boluses), identify the optimal patient population for their postoperative application, and determine the most suitable types of compensatory membranes for use in postoperative radiotherapy for breast cancer.MethodsThis study includes a systematic literature review of sources such as websites, books, and articles from January 2013 to December 2023. We analyzed and compared studies on the use of compensatory membranes in postoperative radiotherapy for breast cancer, evaluating differences among various bolus materials as well as the impact of using no bolus. Outcomes such as patient responses and prognosis were also assessed. After excluding abstracts, reviews, and other non-research articles, a total of 32 studies were included in the analysis.Results3D-printed boluses and brass mesh boluses show promise as alternatives to traditional bolus materials, with potential for broader clinical application. The use of a bolus can increase the incidence of acute radiation-induced toxicities, without significant improvements in long-term patient prognosis. For patients receiving chest wall radiotherapy after breast cancer surgery, bolus use may be considered selectively, especially in those with high-risk factors.ConclusionCurrently, there is no unified standard for bolus use in breast cancer patients undergoing chest wall radiotherapy following modified radical mastectomy. This review provides a critical evaluation of existing literature, summarizing the available bolus materials and their influence on radiotherapy outcomes in postoperative breast cancer treatment.

Indexed as

Breast NeoplasmsFemaleHumansMastectomyRadiotherapy, AdjuvantRadiotherapy Dosage3D printingbrass meshbreast cancerskin toxicitysurface dosetissue equivalent

Identifiers

PMID40485247
PMCPMC12158797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.